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Abstract
Background: Mining gene modules from genomic data is an important step to
detect new gene members of the pathways or other relations such as
protein-protein interactions. In this work, we explore the feasibility of detecting
gene modules by factorizing gene-phenotype associations with phenotype
ontologies rather than the conventionally used gene expression data. In particular,
the hierarchical structure of the ontologies has not been taken full advantage of
in clustering genes and the consistency proposed is believed to be found in the
gene clusters obtained with the method built on the hierarchical structure of
ontologies.
Results: We propose a hierarchal Nonnegative Matrix Factorization
(NMF)-based method, called Consistent Multiple Nonnegative Matrix
Factorization (CMNMF), with which the genome-phenome association matrix
has been factorized into two levels of hierarchical structure among phenotype
ontologies so as to mine gene functional modules. Gene clusters from the
association matrices at two consecutive levels are constrained by CMNMF and
are consistent since the genes are annotated with both the child phenotypes and
the parent phenotypes. CMNMF also restricts the identified phenotype clusters to
be intensively connected within the phenotype ontology hierarchy. In the
experiments on mining functionally related genes from mouse phenotype
ontologies and human phenotype ontologies, CMNMF effectively improves
clustering performance over the baseline methods. Gene ontology enrichment
analysis is also conducted to reveal biologically significant gene modules.
Conclusions: Utilizing the information in the hierarchical structure of
phenotype ontologies, biologically significant gene modules can be identified with
CMNMF. CMNMF also serves as a better tool for detecting new gene members
in the pathways and protein-protein interactions.
Availability: https://github.com/nkiip/CMNMF
Keywords: Non-negative Matrix Factorization; Gene module mining; Phenotype
ontology; Hierarchical structure
Background
Gene functional modules within the genomic data are often identified to find genes
sharing the same functions, being involved in the same pathway or interacting with
each other. To find these functionally related gene sets, clustering methods are
commonly used. K-means and AHC (Agglomerative Hierarchical Clustering) are
the most frequently used clustering algorithms to cluster gene expression data.
Recently, NMF and its variants have also been successfully adopted for clustering
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gene expression [1] and gene-phenotype association data [2]. NMF has advantages
over other methods because of its interpretability and good performance.
More recently, multi-view NMF methods have been proposed. Collective NMF
(ColNMF), proposed by Singh, can get more consistent results by using the shared
coefficient matrix but different basis matrices across different views [3]. Zhang and
Zhou proposed a multiple NMF framework to integrate multiple types of genomic
data to identify microRNA-gene regulatory modules jointly [4]. Additionally, NMF-
based methods integrated with some structure information were also proposed and
have achieved better results. Pehkonen adopted NMF to analyze association data
between gene and Gene Ontology (GO), in which the association matrix has been
enriched according to the “true path rule” [5] of gene ontology hierarchy [6]. Hwang
and Kuang proposed a nonnegative matrix tri-factorization method to cluster phe-
notypes and genes simultaneously [2]. Focusing on predicting missing traits for
plants, HPMF incorporates hierarchical phylogenetic information into matrix fac-
torization [7].
In the context of gene clustering, one useful structural feature that has never been
integrated with multi-view NMF is the hierarchical structure phenotype ontology
which is potentially helpful for clustering genes. In this work, we assume that the
clustering of genes with different representations in multiple views should be consis-
tent, i.e. genes will be consistently clustered by the association with phenotypes at
different levels (or granularity) of the hierarchy in a phenotype ontology, in which
each level of the phenotype ontology provides a different view for clustering genes.
Based on this motivation, we propose a multi-view NMF-based method called
CMNMF (consistent multiple non-negative matrix factorization) for mining func-
tional gene modules, in which the hierarchical structure of phenotype is introduced
as prior knowledge. In detail, a consistency constraint on gene clusters and a hi-
erarchical mapping constraint among the phenotypes in two consecutive levels in
the ontology are introduced in the loss function. In the experiment, we apply CM-
NMF on gene-phenotype association data of mouse and human. CMNMF is com-
pared with the baseline methods by measuring the performance of predicting KEGG
pathways and protein-protein interaction networks. Furthermore, GO enrichment
analysis equipped with DAVID tool [8] is performed to evaluate the biological sig-
nificance of the gene clusters.
Materials and Method
Data Preparation
Mouse gene-phenotype associations were downloaded from Mouse Genome Infor-
matics (MGI)[9] in Feb. 2016, including 15,524 associations between 5,971 pheno-
types and 1,350 genes. More specifically, 3,414 phenotype ontologies were at level
7 and their parents, 2,557 phenotype ontologies were at level 6. The phenotype
ontology levels in our experiment were chosen by the “most frequent level of an-
notation” criterion [10]. Two versions of mouse protein-protein interaction (PPI)
network were obtained from the BIOGRID (Feb. 2016 and Sep. 2016) [11] and two
versions of 292 mouse KEGG pathways (Feb. 2016 and Sep. 2016) were extracted
for evaluation [12].
53,929 human gene-phenotype associations between 3,280 genes and 5,948 phe-
notypes were downloaded in Feb. 2016 from Human Phenotype Ontology (HPO)
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Figure 1: Illustration of the CMNMF framework. (a) The gene-phenotype
associations are divided into two matrices according to the level of phenotype
ontologies, and the two matrices share the same gene set. (b) consistent const-
raint on factorized gene clusters. (c) Hierarchical mapping constraint on the
phenotype ontologies at parent and child levels.
project [13]. 3,707 phenotype ontologies at level 8 and their parents, 2,241 pheno-
type ontologies at level 7, were applied in the following experiments. Two versions
of human PPI networks were obtained from the BIOGRID (Feb. 2016 and Sep.
2016) and two versions of 296 human KEGG pathways (Feb. 2016 and Sep. 2016)
were extracted for evaluation. A table summary of the data used in this paper can
be found in Supporting Information.
Problem Formulation
The notations used in the models are summarized in Table 1. Let n be the number
of genes, m be the number of phenotypes, and the gene-phenotype associations are
represented by a binary matrix A(n×m) with 1 for entries of known associations and
0 otherwise. The loss function of factorizing matrix A is used to derive gene clusters
G(n×k) and phenotype clusters P(k×m) based on gene-phenotype associations, where
k is the number of clusters. The loss function of factorizing matrix A can be defined
as:
L(P ,G) = ||A−GP ||2F . (1)
However, the loss function mentioned above does not consider the hierarchical
structure of phenotype ontologies. To address this problem, we design a framework
by considering phenotypes at different levels in the separate hierarchical structure
separately (Fig. 1(a)). In this framework, we assume the gene clustering derived
from both parent and child phenotype ontology levels should be identical (Fig.
1(b)). In addition, a phenotype mapping constraint is also considered to reinforce
the consistency between learned phenotype clusters at parent level and those at
child level (Fig. 1(c), mapping relations are represented by dot lines). By optimizing
the components mentioned above, we propose a CMNMF algorithm to learn the
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Table 1: Summary of notations.
Notations Explanations
A Genome-phenome association matrix
A1 Genome-phenome association matrix with phenotype
ontology at parent level
A2 Genome-phenome association matrix with phenotype
ontology at child level
G Gene cluster membership matrix
P Phenotype cluster membership matrix
G0 Annotated gene cluster membership matrix
P1 Phenotype cluster membership matrix at parent level
P2 Phenotype cluster membership matrix at child level
M Phenotype ontologies relationship matrix
n Number of genes
m Number of phenotypes
k Number of latent clusters
m1 Number of phenotypes at parent level
m2 Number of phenotypes at child level
gene clusters from gene-phenotype associations with different levels of phenotype
ontologies.
Loss Functions for Penalizing Inconsistency
Motivated by the assumption mentioned above, the phenotype ontologies are di-
vided into two sets according to the two adjacent levels. Two gene-phenotype as-
sociation matrices (A1)n×m1 and (A2)n×m2 are set up based on the original gene-
phenotype association matrix A and the two sets of phenotype ontologies. We as-
sume that the gene clusters Gn×k, derived by matrix factorization on A1 and A2,
should be consistent, although the genes are annotated by phenotype ontologies at
adjacent levels. Gn×k can be derived by optimizing the following loss function:
LC = min
G,P1,P2
‖A1 −GP 1‖2F + α ‖A2 −GP2‖2F , (2)
where α is a hyper-parameter to balance the two matrix factorization problems.
To reinforce the hierarchical mapping relationships between phenotypes at parent
level and child level, the hierarchical mapping constraint on phenotype ontologies
is added to the loss function,
LH =
∑
ij
Mij ||P (i)1 − P (j)2 ||2 (3)
Mm1×m2 denotes the hierarchical mapping relation matrix between phenotype on-
tologies at adjacent levels. Mij is set to 1 if there is a parent-child association
between phenotype i and phenotype j, otherwise 0. We reinforce the hierarchical
mapping constraint by maximizing the similarity between the phenotype ontolo-
gies with parent-child mapping relation in gene-phenotype network A1 and A2. By
combining the two components, the loss function can be formulated as follows:
L = ‖A1 −GP 1‖2F + α ‖A2 −GP2‖2F + β
∑
ij
Mij ||P (i)1 − P (j)2 ||2
s.t. G ≥ 0, P1 ≥ 0, P2 ≥ 0
(4)
where β > 0 is a hyper-parameter to balance the two components.
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The CMNMF Algorithm
To minimize the loss function in Equation (4), an alternative iterative schema is
adopted. It solves the problem with respect to one variable while fixing the other
variables. In the original NMF [14], the loss function in Equation (4) is not convex
on G, P1, and P2 jointly, but it is convex on one variable with the other two fixed.
In the following subsections, the steps of deriving G, P1 and P2 are presented
separately. The complete CMNMF algorithm is outlined in Algorithm 1.
Computation of G in CMNMF
Loss function in Equation (4) can be rewritten as:
L = ‖A1 −GP 1‖2F + α ‖A2 −GP2‖2F + β
(
tr(P1D1P
T
1 ) + tr(P2D2P
T
2 )
− 2tr(P1MP T2 )
) (5)
where (D1)m1×m1 and (D2)m2×m2 are diagonal matrices with (D1)ii =
∑
jMij
and (D2)jj =
∑
iMij respectively. When variables P1 and P2 are fixed, the partial
derivative of Equation (5) with respect to G is:
∂L
∂G
=− 2(A1P T1 −GP1P T1 )− 2α(A2P T2 −GP2P T2 )
and the multiplicative update rule is:
Gij ← Gij (A1P
T
1 + αA2P
T
2 )ij
(GP1P T1 + αGP2P
T
2 )ij
Computation of P1 and P2 in CMNMF
When G is fixed, the partial derivatives of Equation (5) with respect to P1 and P2
are:
∂L(P1)
∂P1
= −2(GTA1 −GTGP1) + 2β(P1D1 − P2MT )
∂L(P2)
∂P2
= −2α(GTA2 −GTGP2) + 2β(P2D2 − P1M)
and the multiplicative update rule is (P2 is fixed when we calculate P1, vice versa):
(P1)ij ← (P1)ij (G
TA1 + βP2M
T )ij
(GTGP1 + βP1D1)ij
(P2)ij ← (P2)ij (αG
TA2 + βP1M)ij
(αGTGP2 + βP2D2)ij
For the loss function of original NMF L(P ,G) = ||A −GP ||2F , it is easy to check
that if G and P are the solutions, then GD, D−1P1 will also form a solution for
any positive diagonal matrix D. To eliminate this uncertainty, in practice it will be
further required that the Euclidean length of each column vector in matrix G is 1
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Algorithm 1 CMNMF
Input: A1: gene-phenotype association matrix at parent level
A2: gene-phenotype association matrix at child level
α, β: hyper-parameters
Output: model parameters G,P1,P2
1: G,P1,P2 ← random values
2: repeat
3: Update Gij ← Gij (A1P
T
1 +αA2P
T
2 )ij
(GP1P
T
1 +αGP2P
T
2 )ij
4: Update (P1)ij ← (P1)ij (G
TA1+βP2M
T )ij
(GTGP1+βP1D1)ij
,
Update (P2)ij ← (P2)ij (αG
TA2+βP1M)ij
(αGTGP2+βP2D2)ij
5: until convergence
6: Normalize Gik ← Gik√∑
iG
2
ik
7: Normalize (P1)kj ← (P1)kj
√∑
iG
2
ik, (P2)kj ← (P2)kj
√∑
iG
2
ik
8: return G,P1,P2
[15, 16]. The matrix P will be adjusted accordingly so that GP does not change.
This can be achieved by:
Gik ← Gik√∑
iG
2
ik
, Pkj ← Pkj
√∑
i
G2ik (6)
This strategy has been adopted in CMNMF as well. After the multiplicative updat-
ing procedure converges, the Euclidean length of each column vector in matrix G
is set to 1 and the matrix P1 and P2 are adjusted with following rules:
Gik ← Gik√∑
iG
2
ik
(P1)kj ← (P1)kj
√∑
i
G2ik, (P2)kj ← (P2)kj
√∑
i
G2ik
(7)
Parameter Tuning
We use old versions of PPI network (Feb. 2016) and KEGG pathways (Feb. 2016)
as validation set to select the best parameters for each method. The selected pa-
rameters have been used in each method to get the performance results by using
new versions of PPI network (Sep. 2016) and KEGG pathways (Sep. 2016) as test
set.
We perform our experiments on two biological datasets, mouse species dataset
and human species dataset. In parameter tuning process, the validation experiment
results for each method have been repeated 10 times independently and the average
results are applied for parameter tuning. As the parameter tuning processes for
mouse data and human data are similar, we show the details on mouse KEGG
pathways data as an illustration. Parameter tuning processes on mouse PPI network
and human data (human KEGG pathways and human PPI network) are described
in Supporting Information.
The hyper-parameters α and β have been tuned by grid with F1 measure. α
balances the contributions of two factorization problems on different phenotype
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Figure 2: F1 scores under different α and β combinations
ontology levels. When α is close to 0, CMNMF becomes NMF. β controls the
hierarchical structure effects of phenotype ontologies. When β is set to 0, CMNMF
becomes ColNMF (Collective NMF) [3]. The performance of CMNMF with different
α and β combinations while taking old versions of mouse KEGG pathways (Feb.
2016) as validation set is shown in Fig. 2. We search α in {0.001, 0.01, 0.1, 1, 10, 100,
1000} and β in {0.001, 0.01, 0.1, 1, 10, 100, 1000}, the darker the color, the higher the
F1 score with the corresponding α and β combinations. In this experiment, α = 100
and β = 1000 are chosen as the best parameters while mouse KEGG pathways data
are used as validation set. The detailed parameter tuning for baseline methods is
described in Supporting Information.
Evaluation
There are two types of evaluation indices: external indices and internal indices [17].
Because internal indices require extracting additional node features for measuring
the similarity between nodes, we choose external indices in the experiments. These
external indices, including F1 measure, Jaccard Index, Rand Index, Precision and
Recall, are applied to show the consistency between the learned gene clusters and
the known KEGG pathways or the gene pairs in the PPI network. The higher the
value, the more consistent the learned gene clusters and the known gene sets are.
Results
In this section, we first demonstrate the properties of CMNMF compared with
NMF on a small MGI mouse gene-phenotype association matrix. Then CMNMF
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is compared with seven baseline methods by evaluating the consistency between
identified gene modules and the new versions of KEGG pathways (Sep. 2016) or gene
pairs in the PPI network (Sep. 2016). Moreover, Gene Ontology enrichment analysis
is performed to evaluate the biological significance of discovered gene modules.
CMNMF on a Small Mouse Gene-Phenotype Associations
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Figure 3: Performance of NMF, CMNMF(β=0) and CMNMF(β=1) on a small
gene-phenotype association matrix. (a) Original gene-phenotype association
matrix A. (b) Matrix A is divided into A1 and A2 according to the level of
phenotype ontology hierarchy. The hierarchical mapping among phenotype
ontologies are represented by dot lines. (c) Clustering result of NMF.
(d) Clustering result of CMNMF(β=0). (e) Clustering result of CMNMF(β=1).
To illustrate the effects of consistency constraint (the first two terms in Equa-
tion (4)) and structure mapping constraint (the last term in Equation (4)), we
demonstrate the performance of NMF, CMNMF(β=0) and CMNMF(β=1) on a
small gene-phenotype association matrix from MGI in Fig. 3(a). The gene set in
the experiment are selected from three mouse KEGG pathways. In detail, Mafa,
Ins2, Abcc8 are from pathway MMU4930 (Type-II diabetes mellitus). Ikbkg, Nfk-
bia, Ctnnb1 are from MMU5215 (Prostate cancer). Tlr4, Vegfa, Tgfb2 are from
MMU5205 (Proteoglycans in cancer). The hierarchical relationships between phe-
notype ontologies associated with selected genes are shown in Fig. 3(b). An effective
algorithm should assign the genes from a KEGG pathway into the same cluster.
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Fig. 3(c), 3(d), and 3(e) represent the clustering results with NMF, CMNMF(β=0)
and CMNMF(β=1), respectively. Compared with Fig. 3(c), the significant improve-
ment can be observed by considering the multiple levels of the hierarchy in the
phenotype ontology in Fig. 3(d) and 3(e). By reinforcing the relationship among
the phenotypes in different levels, CMNMF(β=1) assigns gene Ctnnb1 to the right
cluster comparing with CMNMF(β=0). Note that the clustering result shown in
Fig. 3(e) agrees with gene members in the KEGG pathways.
Comparison with Baseline Methods by Mining Gene Modules
In this section, we evaluate the gene clusters identified by CMNMF with KEGG
pathways and PPI network. Seven clustering methods, agglomerative hierarchi-
cal clustering (AHC) [18], agglomerative hierarchical clustering with pairwise con-
straints [19] (Constrained AHC), K-means, pairwise constrained K-means [20] (Con-
strained K-means), NMF [21], HMF (Hierarchical Matrix Factorization) [22] and
ColNMF (Collective NMF) [3], are compared in the experiment. Please notice AHC
and K-means are unsupervised clustering methods with no parameters, in order
to have a relatively fair comparison with other methods, we introduce additional
pairwise constraints AHC [19] and pairwise constraints K-means [23], the old ver-
sions of KEGG pathways (Feb. 2016) and PPI network (Feb. 2016) are used as
pairwise constraint validation set to help get clustering results. For CMNMF, HMF
and ColNMF, the gene-phenotype association matrixA is divided into two matrices
A1 and A2 according to the levels of phenotype ontologies. For AHC, Constrained
AHC, K-means, Constrained K-means, and NMF, the entire gene-phenotype asso-
ciation matrix is applied. Moreover, the associations to parent phenotype terms in
the ontology have also been included, i.e. using the “true path rule” to enrich the
association matrix. For NMF, HMF, ColNMF and CMNMF, the gene clustering
results are row-normalized by z-score and Gij is set as 0 if it is less than 3. Six
validation indices are reported in Table 2-5.
Table 2: Evaluation results on mouse KEGG pathways.
F1 measure Precision Recall Jaccard Index Rand Index
AHC 0.0871 0.0624 0.1443 0.0455 0.7654
Constrained AHC 0.0925 0.0554 0.2803 0.0485 0.5738
K-means 0.0517 0.0760 0.0392 0.0265 0.8886
Constrained K-means 0.0554 0.0750 0.0439 0.0285 0.8839
NMF 0.1037 0.1084 0.0993 0.0547 0.8668
HMF 0.0818 0.1080 0.0658 0.0426 0.8855
ColNMF 0.0883 0.1074 0.0750 0.0462 0.8799
CMNMF 0.1181 0.0898 0.1726 0.0628 0.8002
Table 3: Evaluation results on mouse PPI.
F1 measure Precision Recall Jaccard Index Rand Index
AHC 0.0037 0.0019 0.1420 0.0019 0.8321
Constrained AHC 0.0080 0.0040 0.6491 0.0040 0.6421
K-means 0.0041 0.0022 0.0426 0.0021 0.9544
Constrained K-means 0.0107 0.0056 0.1197 0.0054 0.9509
NMF 0.0126 0.0065 0.1988 0.0063 0.9305
HMF 0.0137 0.0072 0.1298 0.0069 0.9584
ColNMF 0.0120 0.0062 0.1420 0.0060 0.9478
CMNMF 0.0138 0.0072 0.1521 0.0070 0.9518
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Table 4: Evaluation results on human KEGG pathways.
F1 measure Precision Recall Jaccard Index Rand Index
AHC 0.0808 0.0998 0.0679 0.0421 0.9044
Constrained AHC 0.0952 0.0570 0.2892 0.0500 0.6599
K-means 0.0787 0.0829 0.0748 0.0409 0.8915
Constrained K-means 0.0889 0.0813 0.0980 0.0465 0.8756
NMF 0.0966 0.0891 0.1056 0.0508 0.8778
HMF 0.0863 0.1034 0.0741 0.0451 0.9029
ColNMF 0.0850 0.0869 0.0831 0.0444 0.8893
CMNMF 0.1046 0.0727 0.1886 0.0552 0.8023
Table 5: Evaluation results on human PPI.
F1 measure Precision Recall Jaccard Index Rand Index
AHC 0.0096 0.0055 0.0410 0.0048 0.9709
Constrained AHC 0.0089 0.0045 0.4403 0.0045 0.6637
K-means 0.0095 0.0051 0.0743 0.0048 0.9464
Constrained K-means 0.0117 0.0068 0.0422 0.0059 0.9754
NMF 0.0141 0.0074 0.1457 0.0071 0.9300
HMF 0.0142 0.0077 0.0927 0.0072 0.9557
ColNMF 0.0156 0.0083 0.1303 0.0079 0.9432
CMNMF 0.0166 0.0089 0.1203 0.0084 0.9510
Validation by Known KEGG Pathways and Protein-Protein Interactions
New versions of KEGG pathways (Sep. 2016) and PPI network (Sep. 2016) are
applied as known gene relationships to test the performance of gene clustering re-
sults. Table 2 and Table 3 show the evaluation results on mouse data with KEGG
pathways and PPI network, respectively. The evaluation results on human data
are reported in Table 4 and Table 5. The best results across all the methods are
bold. Comparing with the baseline methods, it is clear that CMNMF outperforms
other methods on F1 measure, Jaccard Index in all cases for both mouse and hu-
man data. It demonstrates the advantage of combining the consistency constraint
with two levels of gene-phenotype association information and the structure con-
straint with parent-child phenotype ontology mapping information. In particular,
comparing with the conventional NMF, the performance of CMNMF is improved
with the additional knowledge from the consistency constraint. Moreover, the phe-
notype structure constraint in CMNMF reinforces the learning results following the
mapping relation in the phenotype ontology, so CMNMF gets better performance
comparing with ColNMF (CMNMF with β = 0). However, AHC works better than
other methods with index “Recall”. We analyse the clustering results of AHC and
find a few large-scale gene clusters (with more than four hundred genes), these large
gene clusters would result in an increase in index “Recall” and a decrease in “Pre-
cision”. The centroid criterion is applied in AHC which tends to find the pair of
clusters that leads to minimum increase in total inter-cluster Euclidean distances
when merging the clusters. Therefore the compact clustering results identified by
AHC will benefit the “Recall” score. We also notice CMNMF does not achieve the
best performance on “Rand Index”. As we know, “Rand Index” takes true negative
gene pairs into consideration, however, in most cases the experiment results are
evaluated on what we have known, i.e. the true positive gene pairs. True negative
gene pairs are dominant in the original data involved in the experiments (account-
ing for 95%-99% of all gene pairs), this would lead to a bias comparison between
different methods. Overall, the CMNMF outperforms all current clustering methods
and the improvement is obvious.
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Validation by Latest Protein-Protein Interactions
CMNMF is also tested on the latest protein-protein interactions added between Feb.
2016 and Sep. 2016 from BIOGRID. The parameters α and β are tuned by the old
version PPI network (Feb. 2016) mentioned in the previous section with F1 measure.
The results are reported in Table 6 and Table 7 for mouse and human data, with
the best α and β respectively. Comparing with baseline methods, CMNMF also
outperforms them on F1 measure, Jaccard Index and Precision.
Table 6: Evaluation results on latest mouse PPI.
F1 measure Precision Recall Jaccard Index Rand Index
AHC 0.0015 0.0008 0.1373 0.0008 0.8330
Constrained AHC 0.0034 0.0017 0.6569 0.0017 0.6417
K-means 0.0017 0.0009 0.0392 0.0009 0.9577
Constrained K-means 0.0045 0.0023 0.1176 0.0022 0.9519
NMF 0.0052 0.0026 0.1936 0.0026 0.9312
HMF 0.0053 0.0027 0.1176 0.0027 0.9593
ColNMF 0.0047 0.0024 0.1324 0.0024 0.9488
CMNMF 0.0055 0.0028 0.1495 0.0028 0.9507
Table 7: Evaluation results on latest human PPI.
F1 measure Precision Recall Jaccard Index Rand Index
AHC 0.0043 0.0023 0.0388 0.0021 0.9727
Constrained AHC 0.0039 0.0019 0.4313 0.0019 0.6639
K-means 0.0040 0.0021 0.0759 0.0020 0.9431
Constrained K-means 0.0041 0.0022 0.0309 0.0020 0.9771
NMF 0.0057 0.0029 0.1309 0.0029 0.9313
HMF 0.0056 0.0029 0.0791 0.0028 0.9572
ColNMF 0.0063 0.0032 0.1160 0.0032 0.9446
CMNMF 0.0065 0.0034 0.1033 0.0033 0.9524
Biological Analysis on Gene Clusters
We further study the functional roles of the identified human gene clusters with
enrichment analysis against Gene Ontology (GO) using DAVID [8]. The enriched
GO terms by selected gene clusters are reported in Table 8, the P-value and FDR
adjusted P-value are also presented. It is clear that gene clusters found by CMNMF
are biological functionally relevant.
By matching the corresponding gene cluster, the genes in No. 239 cluster have
been found associated with prostate cancer. McDonnell found that BCL2 expression
was augmented following androgen ablation and was correlated with the progression
of prostate cancer from androgen dependence to androgen independence [24]. Up-
regulation of epidermal growth factor receptor (EGFR) and subsequent increased in
extracellular-regulated kinase (ERK) and Akt signaling were implicated in prostate
cancer progression [25]. Zhang showed that the FOXO1 protein, a key downstream
effector of the tumor suppressor PTEN, inhibited the transcriptional activity of
Runx2 in prostate cancer cells [26]. Liu examined the effects of TGFA and EGF on
both cell proliferation and 3H-thymidine incorporation in an androgen-dependent
human prostate cancer cell line, ALVA101, in serum-free medium [27].
By matching the corresponding gene cluster, the genes in No. 2 cluster have been
found associated with Parkinson disease. Tanaka analyzed amino acid variations in
the cytochrome b (CYTB) molecule of 64 Japanese centenarians and found out the
most striking feature of centenarian CYTB was the rareness of amino acid variations
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Table 8: Enrichment anaylsis on gene clusters mined by CMNMF with Gene On-
tology
No Gene Cluster Most Related GO Terms P-value FDR
239
BCL2, EGFR, FOXO1,
TGFA, IKBKB,PDGFB,
PDGFRA, CREB3L3, etc.
positive regulation of cell proliferation; 2.2E-06 3.0E-03
wound healing; 1.3E-05 1.8E-02
protein heterodimerization activity; 7.3E-05 7.4E-02
173
CLAM1, NOS1, ITPR1,
ATP2A2, CYCS,GRIN2A,
CACNA1C, COX6A1, etc.
regulation of cardiac muscle contraction 6.8E-07 9.3E-04
by regulation of the release of sequestered calciumion;
regulation of ryanodine-sensitive calcium-release 6.8E-07 9.3E-04
channel activity;
regulation of cardiac muscle contraction; 9.3E-07 1.3E-03
143
BRAF, SMAD3, NRAS,
RAF1, SOS1, TGFB2,
PTPN11, TGFBR1, etc.
intracellular; 2.3E-04 2.1E-01
MAPK cascade; 2.9E-04 4.0E-01
regulation of Rho protein signal transduction; 8.3E-04 1.1E-00
140
CDK4, ERCC1, G6PC,
GAD2,GHR, GPI1,
PDX1,MAFA, etc.
mitochondrial respiratory chain complex I assembly; 5.7E-33 7.6E-30
mitochondrial inner membrane; 5.6E-16 6.0E-13
mitochondrion; 1.8E-09 1.9E-06
127
GRIN1, HTT, LAMC3,
DCTN1, SOD1, TBP,
SLC25A4,NDUFA1, etc.
extracellular matrix organization; 1.5E-07 2.1E-04
cell adhesion; 1.0E-05 1.4E-02
basement membrane; 2.0E-05 1.9E-02
2
CYTB,ND5,ND2,
COX1,ND1,COX3,
ND6,ATP6, etc.
mitochondrial electron transport, NADH to ubiquinone; 2.1E-11 2.0E-08
NADH dehydrogenase (ubiquinone) activity; 2.2E-11 1.5E-08
mitochondrial respiratory chain complex I; 5.8E-09 4.3E-06
The first column is the index of gene clusters identified by CMNMF. For each gene cluster, a
part of genes are presented in the second column. Three most related GO terms, corresponding
P-values and false discovery rate (FDR) are reported in the following columns.
in contrast to the variety of amino acid replacements in patients with Parkinson’s
disease [28]. Heteroplasmic mutations in a specific region of ND5 largely segregated
Parkinson’s disease from controls and might be of major pathogenic importance
in idiopathic Parkinson’s disease [29]. Ksel found a heteroplasmic mtDNAG5460A
missense mutation in the ND2 subunit gene of NADH dehydrogenase was three
times more frequent in Parkinson cases (4/21) compared to controls (5/77). In Ksel’s
study, he provided a hint that the ND25460 mutation, in combination with other
factors, could play a role in disease pathogenesis in a subset of Parkinson patients
[30]. Teismann used acetylsalicylic acid, a COX-1/COX-2 inhibitor, to study the
possible role of the isoenzymes of cyclooxygenase COX-1 and COX-2 in the MPTP
mouse model of Parkinson’s disease [31].
Conclusions
Our results indicate that the gene clusters identified by CMNMF are biologically
relevant with the additional information from phenotype ontology hierarchical struc-
ture. The evaluation experiments on KEGG pathways and PPI network of mouse
and human data show the advantage of CMNMF over other baseline methods.
The experiment on the latest PPI dataset shows the possibility of identifying new
protein-protein interactions. Furthermore, the gene modules identified by CMNMF
are enriched with biologically relevant functions.
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